NOVARTIS
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Their mission is to discover new ways to improve and extend people's lives. They apply their expertise in science and innovation to society’s biggest health challenges. Responsibility is a core part of their business strategy.
NOVARTIS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1996-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.novartis.com
Total Employee:
10001+
Status:
Active
Contact:
+41 61 324 11 11
Email Addresses:
[email protected]
Total Funding:
6.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Google Tag Manager WordPress Content Delivery Network Font Awesome Domain Not Resolving Wordpress Plugins
Similar Organizations
Abomics
Abomics Ltd is an expert company that promotes the application of medical research to patient care.
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Antidote.me
Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.
Vero Biotech
Vero Biotech is a biopharmaceutical company developing products to address the medical needs of patients with pulmonary, cardiac diseases.
MedCompared
MedCompared is a health comparison site that helps you to choose your prescribed medication for the best price in the best online pharmacy.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Novartis India
Novartis India is a healthcare company that address needs and deliver better patient outcomes.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
PharmaLead
PharmaLead is a healthcare company that advises and improves pharmacies in the re-design of business processes and business operations.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-22 | Gyroscope Therapeutics | Gyroscope Therapeutics acquired by Novartis | 1.5 B USD |
| 2021-09-17 | Arctos Medical | Arctos Medical acquired by Novartis | N/A |
| 2021-06-01 | Cellerys | Cellerys acquired by Novartis | N/A |
| 2020-12-17 | Cadent Therapeutics | Cadent Therapeutics acquired by Novartis | 770 M USD |
| 2020-10-29 | Vedere Bio ll | Vedere Bio ll acquired by Novartis | 280 M USD |
| 2020-04-20 | Amblyotech | Amblyotech acquired by Novartis | N/A |
| 2019-11-24 | The Medicines Company | The Medicines Company acquired by Novartis | 9.7 B USD |
| 2019-05-09 | Xiidra | Xiidra acquired by Novartis | 1.9 B USD |
| 2018-12-21 | CellforCure | CellforCure acquired by Novartis | N/A |
| 2018-10-18 | Endocyte | Endocyte acquired by Novartis | N/A |
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Novartis
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-25 | Aktis Oncology | Novartis investment in Series A - Aktis Oncology | 84 M USD |
| 2022-07-25 | Cleerly | Novartis investment in Series C - Cleerly | 223 M USD |
| 2022-06-22 | Alladapt Immunotherapeutics | Novartis investment in Venture Round - Alladapt Immunotherapeutics | 119 M USD |
| 2022-05-19 | Deciphex | Novartis investment in Series B - Deciphex | 11.5 M USD |
| 2022-03-04 | Klarah | Novartis investment in Grant - Klarah | 20 K USD |
| 2022-03-04 | Parrots | Novartis investment in Pre Seed Round - Parrots | 100 K USD |
| 2021-12-07 | Freenome | Novartis investment in Series D - Freenome | 300 M USD |
| 2021-12-06 | Holmusk | Novartis investment in Venture Round - Holmusk | N/A |
| 2021-12-02 | Medtech Africa | Novartis investment in Grant - Medtech Africa | 20 K USD |
| 2021-11-09 | Mekonos | Novartis investment in Series A - Mekonos | 25 M USD |
Newest Events participated
Participated in Webit Festival Europe
on 2020-06-17 as sponsor
Key Employee Changes
Official Site Inspections
http://www.novartis.com Semrush global rank: 104.19 K Semrush visits lastest month: 941 K
- Host name: 104.18.1.16
- IP address: 104.18.1.16
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Novartis" on Search Engine
Novartis announces new organizational structure to accelerate …
Apr 04, 2022. Ad hoc announcement pursuant to Art. 53 LR. New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity. Integrating Pharmaceuticals and Oncology business units into an Innovative Medicines (IM) …See details»
Novartis organizational structure
Novartis organizational structure. Last updated: December 2023. Fiona H. Marshall. President, Biomedical Research. Harry Kirsch. Chief Financial Officer. Charlotte Pamer -Wieser. Corporate Secretary . Joerg Reinhardt. Board Chair. Elizabeth Doherty. Chair, Audit and Compliance CommitteeSee details»
About | Novartis
Our strategy. Deliver high value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. Our footprint. 78k. Employees. 140+. Nationalities. 284m. Patients reached. Download the Novartis in Society Integrated Report 2023 for more details (PDF 8.4 MB)See details»
Novartis - Wikipedia
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.See details»
Novartis announces new organizational structure - World Pharma …
05 April 2022. Novartis announced the introduction of a new organizational structure and operating model designed to support the company’s innovation, growth, and productivity ambitions as a focused medicines company in the coming decade.See details»
Who we are - Novartis Annual Review 2020
Our purpose. We reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.See details»
Our business environment - Novartis in Society Integrated Report …
Novartis in Society. Our approach. Our business environment. The need for high-quality healthcare has never been more urgent or important. People around the world are living longer, fueling a rise in chronic diseases and pressuring healthcare systems to restrain spending growth.See details»
Novartis announces new organizational structure to
Basel, April 4, 2022 — Novartis today announced the introduction of a new organizational structure and operating model designed to support the company’s innovation, growth, and productivity...See details»
Novartis Canada launches new head office in the Health
MONTRÉAL, May 18, 2023 /CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce the official opening of its new Montréal office in the heart of Old Montréal.See details»
Company overview | Novartis
About Novartis. Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.See details»
The Culture And Leadership Code Of Novartis - Forbes
Jan 20, 2021 To learn more about how Novartis scales leadership development as a sales powerhouse, I spoke with Alison Pulte, associate director of leadership development for Novartis’ U. S.-based first- and ...See details»
Novartis announces new organizational structure to accelerate …
April 4, 2022 at 1:00 AM · 9 min read. Novartis Pharma AG. Ad hoc announcement pursuant to Art. 53 LR. New simplified structure and operational set-up supports Novartis strategy as a focused...See details»
Novartis Foundation - Wikipedia
The Novartis Foundation (formerly known as the Novartis Foundation for Sustainable Development) is a non-profit organization and part of the corporate responsibility portfolio of Novartis in Basel, Switzerland. The foundation conducts projects to improve health, mostly in sub-Saharan Africa and in south-east Asia . History.See details»
Novartis announces changes to the Executive Committee
Basel, May 16, 2018 - Novartis announced today that Felix R. Ehrat, Group General Counsel of Novartis, has decided to retire from the company. Shannon Thyme Klinger, currently Chief Ethics, Risk and Compliance Officer, will be appointed Group General Counsel, effective June 1, 2018.See details»
Novartis - Crunchbase Company Profile & Funding
Organization. Novartis. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Novartis is a healthcare company that provides solutions to address the evolving needs of patients worldwide. Basel, Basel-Stadt, Switzerland. 10001+. Grant. Public. www.novartis.com. 517. Stock Symbol NYSE:NVS. Acquisitions 33.See details»
Novartis Foundation
Advancing digital and data-led approaches to population health. The Novartis Foundation focuses on the world’s most pressing health challenges: cardiovascular disease and health inequity.See details»
Top Novartis executives to depart as company restructures
Apr 4, 2022 Dive Brief: Three top Novartis executives, including chief medical officer John Tsai, are leaving the Swiss drugmaker alongside a restructuring that’s meant to streamline operations and save at least $1 billion in annual expenses by 2024.See details»
How Novartis pivoted to a skills-based organization | Gloat
$1.3M. in savings through internal projects. Record-setting increase in employee satisfaction with career and development opportunities. Show Details. Industry: Electronics. Company size: 43,000. Seagate thrived through the pandemic. $35M ROI. through savings in external recruiting, termination costs, and unlocked hours. 58% increase.See details»
Novartis 'actively' reviewing relationships with Chinese …
Apr 23, 2024 Novartis, like many drugmakers, has ties to Chinese firms in the manufacturing and contract research space, the Swiss pharma’s CFO, Harry Kirsch, said on a press call Tuesday during its first ...See details»
People and culture | Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.See details»